FDA Letters

FDA: Getting tough with everyone

OB-HT058_oci_BA_20100304091109
Welcome to a new tougher FDA. Not only are they increasing their regulatory oversight they intend to put people in jail. The FDA plans to increase prosecutions of pharmaceutical and food industry executives as part of an effort to refocus its criminal division which has been under attack in Congress and is criticized in a new government report, the WSJ said this morning. Read More...
|

DDMAC now interpreting TV ad creatives

images
Attention DTC marketers: your approval process for TV ads just became a lot harder. In a letter to the makers of Aricept DDMAC objected to the creative content as follows "these presentations imply that, as a result of Aricept treatment, patients’ cognitive and daily functioning, specifically aspects of attention and focus, orientation, communication, and social interaction and engagement, will be restored to normal." as an overstatement of efficacy. Read More...
|

Adcica (Cialis) letter from the FDA

me479
And you thought Cialis was just for men with ED. Adcirca (Cialis 40mg) just received a letter from the FDA for omitting key risk information from their website and for misleading patient videos. United Therapeutics licensed the rights to develop, market, promote and commercialize Adcirca for pulmonary hypertension in the United States and Puerto Rico from Eli Lilly & Company in November 2008. Read More...
|

More Stuff